An intermediate in the preparation of antitumor agents and tyrosine kinase inhibitors
References: Majesky, M., et al.: J. Cell. Biol., 111, 2149 (1990), Claesson-Welsh, L., et al.: J. Biol. Chem., 269, 32023 (1994), Showalter, H., et al.: Pharmacol. Ther., 76, 55 (1997), Klutchko, S., et al.: J. Med. Chem., 41, 3276 (1998),
{{ product.accreditations.length <= 2 ? product.accreditations[0].name : product.accreditations.map(e => e.name).join(', ') }} Accredited within the boundaries of LGC’s fixed and flexible scope of UKAS accreditation. Further details can be found in the scheme description. ISO/IEC 17043 Specifies general requirements for the competence of providers of proficiency testing schemes and for the development and operation of proficiency testing schemes. Find out more.